New methods of MRI scanning hold promise
Researchers in Gisborne, New Zealand, are testing ultra-high contrast MRI technology to improve the early detection and monitoring of multiple sclerosis. The study aims to enhance treatment planning and quality of life for those living with the condition.
Why it matters
Advancements in diagnostic imaging are critical for managing chronic neurological conditions and improving long-term patient outcomes.
MS Society Gisborne-East Coast community adviser Karen Whitehead (left) and Mātai Medical Research Institute senior administrator Alisha Duncan spread the word about MS and research efforts to improve the quality of life for those with the condition.
Gisborne is at the forefront of research into new methods of MRI scanning that could benefit people with multiple sclerosis (MS).
Researchers from Mātai Medical Research Institute in Gisborne are investigating the use of ultra-high contrast (UHC) magnetic resonance imaging (MRI) in the detection and monitoring of MS.
The new technology is said to open the way to earlier diagnosis, better treatment planning and potentially life-altering early interventions.
Volunteers among Gisborne people with MS are part of the study.
Last week was MS Awareness Week (September 14 to 20) and the theme, “Time Matters in MS”, focused on early signs and timely diagnosis. The condition affects more than 5000 people in New Zealand.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in